<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05118659</url>
  </required_header>
  <id_info>
    <org_study_id>CSEULS-PI-198/2018</org_study_id>
    <nct_id>NCT05118659</nct_id>
  </id_info>
  <brief_title>Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo</brief_title>
  <official_title>Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo. A Randomized And Controlled Clinic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Universitario La Salle</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Universitario La Salle</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This analysis aims to evaluate the immediate effect that cervical sustained natural&#xD;
      apophyseal glides (SNAGs) have on a group of individuals with induced vertigo by a caloric&#xD;
      vestibular stimulation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 3, 2018</start_date>
  <completion_date type="Actual">June 28, 2018</completion_date>
  <primary_completion_date type="Actual">June 4, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>vHIT (Video Head Impulse Test)</measure>
    <time_frame>15 minutes</time_frame>
    <description>Detection of peripheral vestibular deficits and their recovery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>5 minutes</time_frame>
    <description>state-trait anxiety was measured at the beginning of the study using the Spanish version of the trait-state anxiety inventory (STAI)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Vertigo</condition>
  <arm_group>
    <arm_group_label>SNAG GROUP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The SNAG group received a treatment based on sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each, combined with active cervical extension.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SHAM SNAG GROUP</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The placebo SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL GROUP</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group did not receive any type of intervention, they only waited for four minutes, sat down on a chair</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sustained natural apophyseal glides</intervention_name>
    <description>It consists on a sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each</description>
    <arm_group_label>SNAG GROUP</arm_group_label>
    <other_name>SNAG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SHAM SNAG</intervention_name>
    <description>Subjects on SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension</description>
    <arm_group_label>SHAM SNAG GROUP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy subjects,&#xD;
&#xD;
          -  Age 18-44 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Consume of antipsychotics, antidepressants, antiarrythmics and/or anticonvulsivants&#xD;
&#xD;
          -  Hippoacusia&#xD;
&#xD;
          -  Auditory diseases&#xD;
&#xD;
          -  Peripheral or central vestibulopathies&#xD;
&#xD;
          -  Cerviogenic dizziness&#xD;
&#xD;
          -  Balance disorders&#xD;
&#xD;
          -  Nistagmus&#xD;
&#xD;
          -  Oculomotor nerve dysfunctions&#xD;
&#xD;
          -  Migraine&#xD;
&#xD;
          -  Cervical osteoporosis, lashing or fracture&#xD;
&#xD;
          -  Discal cervical hernia&#xD;
&#xD;
          -  Cervical neuropathy&#xD;
&#xD;
          -  Psychriatic disorders&#xD;
&#xD;
          -  Epilepsy&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CSEU La Salle</name>
      <address>
        <city>Madrid</city>
        <zip>28023</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jose V Leon Hernandez</name>
      <address>
        <city>Madrid</city>
        <zip>28023</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 19, 2021</study_first_submitted>
  <study_first_submitted_qc>November 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Universitario La Salle</investigator_affiliation>
    <investigator_full_name>Jose Vicente Leon Hernandez</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vertigo</mesh_term>
    <mesh_term>Dizziness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will only be treated by study researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

